Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "PharmaTimes" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about PharmaTimes for you to read. Along with our medical data and news we also list PharmaTimes Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaTimes Companies for you to search.
It’s not too late! The deadline for the PharmaTimes Clinical Researcher of the Year (CROY) 2019 awards has been extended to the February 25.
The National Institute for Health and Care Excellence has recommended Eli Lilly’s Verzenios in combination with an aromatase inhibitor as treatment option for locally advanced or metastatic breast cancer
Janssen’s new treatment for prostate cancer Erleada has been licensed by the European Commission.
Footcare brand Scholl has announced it is joining forces with The College of Podiatry (COP) to raise awareness of foot health.
Queen’s University researchers have developed a new test to detect disease and infection that could save time, money and possibly lives.
The National Institute for Health and Care Excellence has announced that an “exciting development” could increase the number of livers which can be safely used for transplantation.
A study carried out by researchers from the University of Cambridge, National Cancer Institute, National Institutes of Health in the US among others has shown how putting different genetic and risk factor data into a prediction equation could help us understand how likely a woman is to develop breast cancer.
GlaxoSmithKline subsidiary Adriatic Acquisition Corporation (AAC) has extended the expiration date for its tender offer for US-based Tesaro.
Pharmaceutical groups weigh in on the UK parliament’s rejection of the Brexit withdrawal agreement.
Over a thousand people with psychosis are still waiting for treatment on the NHS.
The Royal Pharmaceutical Society has begun to produce its first ever ‘Professional Standards for Community Pharmacy Services’.
Merck’s Keytruda has been found to reduce risk of death by 31% compared to chemotherapy, when used in previously treated patients with advanced esophageal or esophagogastric junction carcinoma, whose tumours express PD-L1.
Responding to the NHS’ long-term funding plan, experts have cautioned that for progress to be made, the funding must be protected for an appropriate time period.
The European Commission has approved Bristol-Myers Squibb's Opdivo in combination with low-dose Yervoy for first-line treatment of patients with intermediate and poor risk advanced renal cell carcinoma (RCC).
The Scottish Medicines Consortium (SMC) has recommended Perjeta on the NHS.
Seqirus has announced European approval of its new cell-based quadrivalent influenza vaccine.
Health Canada has placed restrictions on Allergan's uterine fibroid treatment Esmya, after discovering a possible link between its use and the risk of a rare but serious liver injury.
Environment secretary Michael Gove has launched a new 'world leading plan' to tackle air pollution.
A new report on current trends in Schizophrenia services in the UK launched by Janssen has found that mental health services are falling behind physical health services.
Speed of recruitment and demand for a trial assessing the impact of HIV prevention therapy PrEP has significantly exceeded initial predictions, leading researchers to consider increasing the number of participants from 13,000 to up to 26,000.
A new Pegasus study has found that Generation Z (aged 16-23) has an overwhelming concern that UK health services won’t meet their needs or expectations in the future.
The European Medicines Agency (EMA) has approved Flutiform pMDI for use in the treatment of children with asthma aged five years and over.